Supervised atenolol therapy in the management of hemodialysis hypertension

Kidney International - Tập 55 Số 4 - Trang 1528-1535 - 1999
Rajiv Agarwal1
1Department of Medicine, Indiana University and RLR VA Medical Center, Indianapolis, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Charra, 1992, Survival as an index of adequacy of dialysis, Kidney Int, 41, 1286, 10.1038/ki.1992.191

Silberberg, 1989, Impact of left ventricular hypertrophy on survival in end-stage renal disease, Kidney Int, 36, 286, 10.1038/ki.1989.192

Rostand, 1991, Cardiovascular complications in renal failure, J Am Soc Nephrol, 2, 1053, 10.1681/ASN.V261053

Charra, 1994, Control of blood pressure in long slow hemodialysis, Blood Purif, 12, 252, 10.1159/000170171

Salem, 1995, Hypertension in the hemodialysis population: A survey of 649 patients, Am J Kidney Dis, 26, 461, 10.1016/0272-6386(95)90492-1

Jacobs, 1984, Control of blood pressure in patients treated by maintenance hemodialysis: Efficacy of dialysis and contribution of antihypertensive drugs, Contrib Nephrol, 41, 128, 10.1159/000429275

Cheigh, 1992, Hypertension is not adequately controlled in hemodialysis patients, Am J Kidney Dis, 19, 453, 10.1016/S0272-6386(12)80954-1

Kooman, 1992, Blood pressure during the interdialytic period in haemodialysis patients: Estimation of representative blood pressure values, Nephrol Dial Transplant, 7, 917, 10.1093/ndt/7.9.917

Luik, 1994, Diurnal blood-pressure variations in haemodialysis and CAPD patients, Nephrol Dial Transplant, 9, 1616

Baumgart, 1991, Blood pressure elevation during the night in chronic renal failure, hemodialysis and after renal transplantation, Nephron, 57, 293, 10.1159/000186278

Verdecchia, 1990, Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension, Circulation, 81, 528, 10.1161/01.CIR.81.2.528

Ritz, 1993, Morbidity and mortality due to hypertension in patients with renal failure, Am J Kidney Dis, 21, 113, 10.1016/0272-6386(93)70102-5

Ritz, 1993, Hypertension and cardiac death in dialysis patients: Should target blood pressure be lowered?, Semin Dial, 6, 227, 10.1111/j.1525-139X.1993.tb00145.x

Neutel, 1993, Application of ambulatory blood pressure monitoring in differentiating between antihypertensive agents, Am J Med, 94, 181, 10.1016/0002-9343(93)90181-N

Flouvat, 1980, Pharmacokinetics of atenolol in patients with terminal renal failure and influence of haemodialysis, Br J Clin Pharmacol, 9, 379, 10.1111/j.1365-2125.1980.tb01065.x

Fitzgerald, 1978, Studies on the pharmacokinetics and pharmacodynamics of atenolol in man, Eur J Clin Pharmacol, 13, 81, 10.1007/BF00609750

Kirch, 1981, Pharmacokinetics of atenolol in relation to renal function, Eur J Clin Pharmacol, 19, 65, 10.1007/BF00558387

Niedermayer, 1978, Pharmacokinetics of antihypertensive drugs (atenolol, metoprolol, propranolol and clonidine) and their metabolites during intermittent haemodialysis in humans, Proc Eur Dial Transplant Assoc, 15, 607

Blomqvist, 1988, Pharmacokinetics and pharmacodynamics of controlled-release metoprolol: A comparison with atenolol, Eur J Clin Pharmacol, 33, S19, 10.1007/BF00578408

De Fremont, 1979, Clin Nephrol, 12, 198

Maggiore, 1975, Long-term propranolol treatment of resistant arterial hypertension in haemodialysed patients, Clin Sci Mol Med, 48, 73s

Fishbane, 1997, Role of volume overload in dialysis-refractory hypertension, Am J Kidney Dis, 28, 257, 10.1016/S0272-6386(96)90309-1